IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025)
IGC Pharma (IGC) reported Exchange Rate Effect of $5000.0 for Q3 2025, up 145.45% year-over-year from $2037.0 in Q3 2024, and down 80.0% quarter-over-quarter from $25000.0 in Q2 2025.
IGC Pharma (IGC) Exchange Rate Effect (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has 16 years of Exchange Rate Effect data on file, last reported at $5000.0 in Q3 2025.
- Exchange Rate Effect for Q3 2025 came in at $5000.0, up 145.45% year-over-year; the trailing twelve-month figure through Sep 2025 was $32000.0 (up 633.33% YoY), and the FY2026 annual result was -$10000.0, down 42.86% from the prior year.
- Exchange Rate Effect fell to $5000.0 in Q3 2025 per IGC's latest filing, from $25000.0 in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $25000.0 in Q2 2025 and troughed at -$52000.0 in Q2 2022.
- A 5-year average of -$5111.1 and a median of $1000.0 in 2023 frame the typical range for Exchange Rate Effect.
- The sharpest annual moves came in 2022 and 2025: Exchange Rate Effect sank 3900.0% in 2022, then surged 1150.0% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $14000.0 in 2021, then tumbled by 192.86% to -$13000.0 in 2022, then soared by 107.69% to $1000.0 in 2023, then tumbled by 1200.0% to -$11000.0 in 2024, then surged by 145.45% to $5000.0 in 2025.
- Business Quant data shows IGC's Exchange Rate Effect at $5000.0 in Q3 2025, $25000.0 in Q2 2025, and $2000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 8.68 Mn |
| 10 | IGC Pharma | 27.49 Mn | 27.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 5,000.00 |
| Sep 30, 2025 | 5,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Jun 30, 2025 | 25,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 2,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Sep 30, 2024 | -11,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Sep 30, 2023 | -10,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Jun 30, 2023 | 1,000.00 |
| Mar 31, 2023 | 11,000.00 |
| Mar 31, 2023 | 11,000.00 |